Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2021-03-25 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
关于召开2020年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2020 Annual General Meeting (AGM) of Yunnan Watson Biotechnology Co., Ltd. It includes information about the meeting date, voting procedures, proposals to be discussed, registration details, and proxy forms. The document does not contain the actual annual report or financial statements but rather the announcement and procedural details for the AGM. It specifically mentions the 2020 annual report and other reports will be reviewed at the meeting, but these are not included in the document itself. The length is about 4998 characters, and the content is consistent with an AGM Information notice rather than the report itself or voting results. Therefore, the appropriate classification is AGM Information (AGM-R).
2021-03-25 Chinese
关于举行2020年度业绩网上说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about holding an online performance briefing for the 2020 annual results. It references the 2020 annual report already disclosed on March 26, 2021, and invites investors to participate in a webcast to discuss the results. The document is short (717 characters) and does not contain actual financial statements or detailed financial data. It is an announcement of an event related to the annual report, not the report itself. Therefore, it fits best under Investor Presentation (IP) as it is a detailed presentation event for investors focusing on financials and company strategy.
2021-03-25 Chinese
关于2020年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from a company regarding its 2020 annual profit distribution plan, including details on cash dividends per share and the approval process involving the board of directors, supervisory board, and independent directors. It explicitly states that the profit distribution plan is subject to approval at the shareholders' meeting. The document does not contain full financial statements or comprehensive financial performance data but focuses on dividend distribution details and related approvals. The document length is short (1793 characters), and it is an announcement of a profit distribution plan rather than a full annual report or earnings release. Therefore, it fits best into the category of Notice of Dividend Amount (DIV).
2021-03-25 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 21st meeting of the 4th Board of Directors of Yunnan Watson Biotechnology Co., Ltd. It includes approvals of various reports such as the 2020 audited financial report, 2020 annual report, internal control self-evaluation report, social responsibility report, profit distribution plan, and other corporate governance matters. The document also mentions that these reports and opinions are available on the designated disclosure website (巨潮资讯网). The document is a formal board meeting resolution announcement, not the reports themselves. It is not a full annual report (10-K) or audit report (AR) but rather a board/management information announcement about the approval of these reports and related corporate decisions. The document length is about 4726 characters, which is relatively short and consistent with a board meeting resolution announcement. Therefore, the best fitting category is Board/Management Information (MANG).
2021-03-25 Chinese
平安证券股份有限公司关于公司调整部分募集资金投资项目达到预定可使用状态时间的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from Ping An Securities regarding the adjustment of the expected usable date of certain fundraising investment projects by Yunnan Watson Biotechnology Co., Ltd. It discusses the progress and adjustment of the investment project timelines related to the use of raised funds. The document references regulatory compliance with securities laws and stock exchange rules, and includes opinions from the board, supervisors, independent directors, and the sponsoring institution. The content is focused on the verification and approval of changes in the use of raised funds, not a full financial report or earnings release. The document length is 3175 characters, which is relatively short and primarily an official verification opinion rather than a full report. This fits best under Regulatory Filings (RNS) as it is a regulatory compliance document and verification opinion rather than a full audit report or annual/interim report.
2021-03-25 Chinese
2020年度社会责任报告
Environmental & Social Information Classification · 95% confidence The document is titled "2020 年度社会责任报告 暨环境、社会及治理（ESG）报告" which translates to "2020 Annual Social Responsibility Report and Environmental, Social and Governance (ESG) Report". It is issued by Yunnan Walvax Biotechnology Co., Ltd. The content includes detailed descriptions of the company's social responsibility activities, ESG management structure, governance, environmental responsibility, social responsibility, and related performance metrics for the year 2020. It references ESG indices and sustainability guidelines such as GRI and Shenzhen Stock Exchange guidelines. The document is comprehensive and focused on the company's environmental, social, and governance performance rather than financial results or regulatory filings. It is not an annual report (10-K), earnings release, or management discussion. It is not a proxy statement or voting results announcement. It is a detailed ESG report, which fits the category of Environmental & Social Information (SR). The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement or summary.
2021-03-25 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.